SBFM

Conviction 0HealthcareScan · Fri, Oct 9, 2026

Sunshine Biopharma Inc. (SBFM) closed at $0.3378 (-21.44%) on Oct 9, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 29, RS Rating 1, -98.3% from its 52-week high, -97.1% year to date. Sector: Healthcare · Pharmaceutical Preparations.

SBFM$0.3378-21.44%

ResistanceSupportVol 14

Vol MA14 22.23M

Jul 14Jul 30Aug 18Sep 3Sep 23Oct 9

Sunshine Biopharma Inc.Pharmaceutical Preparationswww.sunshinebiopharma.com ↗

Price0.3378

Change-21.44%

Gap-6.98%

Rel volume0.86×

Avg volume15.93M

Avg $ vol9.23M

SMA 200.7610

SMA 501.01

SMA 2005.83

Price vs 50-66.93%

Price vs 200-94.26%

MA stackbearish

50/200 cross—

Supertrenddown · 0.9699

RSI (14)29

MACD hist-0.03

MACD cross—

Stoch %K / %D0 / 12

ADX (14)31

+DI / −DI44 / 23

RSI divergence—

MACD divergence—

ATR %52.67%

ADR %19.06%

52w high19.80

52w low0.3347

From 52w high-98.31%

Above 52w low+0.00%

New 52w highNo

SqueezeOff

Bollinger width110.99%

%B-0.00

Donchian pos0.14%

Donchian high1.56

Donchian low0.3330

AVWAP (52w high)2.30

vs AVWAP high-85.42%

AVWAP (52w low)0.3559

vs AVWAP low-5.96%

OBV trendFlat

Chaikin MF (20)-0.28

Today vs 20d0.86×

Avg vol (14d)22.68M

Avg vol (20d)15.93M

Avg $ vol (20d)9.23M

Market cap1.3M

RS Rating1 / 99

RS 3m (vs SPY)-86.75%

RS 6m (vs SPY)-110.85%

RS line new highNo

Trend template0/8

Technical rank1.0

1 week-49.78%

1 month-69.01%

3 months-82.84%

6 months-96.28%

1 year-97.79%

YTD-97.09%

P/E-0.22

P/B0.05

P/S0.04

P/FCF-0.24

EPS-7.32

Div yield—

ROE-21.70%

ROA-17.77%

Debt/Eq0.07

Current5.46

EV/EBITDA2.78

Gross margin33.76%

Net margin-16.46%

Rev growth4.11%

EPS growth-16.39%

Price target—

Target upside—

Analyst rating—

Institutional0.36%

Ent. value-16.38M

Revenue9.26M

Net income-1.56M

Gross profit2.43M

Free cash flow-5.51M

IndustryPharmaceutical Preparations

ExchangeNasdaq

Shares out2.12M

Employees50

ListedThu, Aug 9, 2007

Free float4.9M

Float %100.0%

Short interest86.93K

Days to cover0.1d

Short volume61.2%

Squeeze score18 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.15

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank1.0 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.44

Support0.5672

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SBFM

All disclosures →

No recent disclosed trades by Congress in SBFM. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SBFM

Insider	Side	Shares	Value	Traded	Filed
NATAN DAVID Director · Common Stock · 2026-08-07	Grant	58.3K	—	2026-08-07	2026-08-11
NATAN DAVID Director · Common Stock · 2026-04-14	Grant	100K	$0	2026-04-14	2026-04-14

SEC filings

EDGAR filings in SBFM · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

SBFM

Recent news

Get daily signals & real-time alerts.